Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Korsatko, S; Glettler, K; Olsen, KJ; Wutte, A; Bock, G; Koehler, G; Mader, JK; Semlitsch, B; Pieber, TR.
A direct comparison of the pharmacodynamic properties of insulin detemir and neutral protamine lispro (NPL) insulin in patients with type 1 diabetes.
Diabetes Obes Metab. 2013; 15(3):241-245
Doi: 10.1111/dom.12016
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
-
Korsatko Stefan
-
Pieber Thomas
- Co-authors Med Uni Graz
-
Köhler Gerd
-
Mader Julia
-
Semlitsch Barbara
-
Treiber Gerlies
-
Wutte Andrea-Maria
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Aims To compare the pharmacodynamic properties of insulin detemir (detemir) and neutral protamine lispro (NPL) insulin using a euglycaemic glucose clamp. Methods In a double-blind, crossover study, 30 patients with C-peptide negative type 1 diabetes were randomly assigned to a single dose (0.4 U/kg) of detemir and NPL. Plasma glucose (PG) was normalized with a variable insulin infusion and then decreased stepwise, followed by a euglycaemic clamp at 5.5 mmol/l over 32 h. Duration of action was defined as time from dosing until PG exceeded 8.3 mmol/l for at least 30 min. Results Duration of action was similar for detemir [23.0 (range 2.2532) h] and NPL [22.0 (9.532) h], p?=?0.55. Using glucose infusion rate (GIR) parameters, detemir showed a flatter pharmacodynamic profile versus NPL: area under the curve, AUCGIR(032)?=?1326 vs. 1841 mg/kg, p?0.01 (detemir vs. NPL, respectively); AUCGIR(012)?=?784 vs. 1392 mg/kg, p?0.05; AUCGIR(1232)?=?455 vs. 274 mg/kg, p?=?0.051; GIRlate(1232)/GIRearly(012) ratio?=?0.33 vs. 0.04, p?0.001. Detemir also showed a lower and later peak of action than NPL [GIRmax 2.0 vs. 3.2 mg/kg/min, p?0.01; Tmax 9.1 (95% confidence interval: 3.014.7) vs. 7.0 h (1.815.2)]. Conclusions Detemir and NPL had similar duration of action of approximately 24 h in patients with type 1 diabetes. Compared with NPL, detemir had a flatter profile with a more even distribution of metabolic effect over 24 h.
- Find related publications in this database (using NLM MeSH Indexing)
-
Adult -
-
Area Under Curve -
-
Blood Glucose - drug effects Blood Glucose - metabolism
-
Body Mass Index -
-
Cross-Over Studies -
-
Diabetes Mellitus, Type 1 - blood Diabetes Mellitus, Type 1 - drug therapy
-
Dose-Response Relationship, Drug -
-
Double-Blind Method -
-
Female -
-
Glucose Clamp Technique - methods
-
Humans -
-
Hypoglycemic Agents - administration & dosage Hypoglycemic Agents - pharmacology
-
Insulin - administration & dosage Insulin - analogs & derivatives Insulin - pharmacology
-
Insulin, Long-Acting - administration & dosage Insulin, Long-Acting - pharmacology
-
Male -
-
Protamines - administration & dosage Protamines - pharmacology
- Find related publications in this database (Keywords)
-
insulin analogues
-
insulin therapy
-
pharmacodynamics
-
randomized trial
-
type 1 diabetes